Enzon Pharmaceuticals, Inc. (ENZN) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Cranford, NJ, 미국. 현재 CEO는 Richard L. Feinstein.
ENZN 을(를) 보유 IPO 날짜 1984-02-15, 에 상장 Other OTC, 시가총액 $4.45M.
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
